Hepion Pharmaceuticals Inc (HEPA)
1.14
-0.03
(-2.56%)
USD |
NASDAQ |
May 23, 16:00
1.14
0.00 (0.00%)
After-Hours: 20:00
Hepion Pharmaceuticals Total Assets (Quarterly): 18.09M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.09M |
| September 30, 2023 | 25.00M |
| June 30, 2023 | 36.50M |
| March 31, 2023 | 49.50M |
| December 31, 2022 | 60.24M |
| September 30, 2022 | 69.70M |
| June 30, 2022 | 83.57M |
| March 31, 2022 | 95.86M |
| December 31, 2021 | 103.55M |
| September 30, 2021 | 111.60M |
| June 30, 2021 | 119.75M |
| March 31, 2021 | 123.76M |
| December 31, 2020 | 48.65M |
| September 30, 2020 | 20.36M |
| June 30, 2020 | 24.08M |
| March 31, 2020 | 23.27M |
| December 31, 2019 | 20.61M |
| September 30, 2019 | 21.07M |
| June 30, 2019 | 23.34M |
| March 31, 2019 | 7.904M |
| December 31, 2018 | 8.189M |
| Date | Value |
|---|---|
| September 30, 2018 | 14.38M |
| June 30, 2018 | 7.975M |
| March 31, 2018 | 9.396M |
| September 30, 2017 | 14.12M |
| June 30, 2017 | 18.38M |
| March 31, 2017 | 11.76M |
| December 31, 2016 | 16.07M |
| September 30, 2016 | 8.816M |
| June 30, 2016 | 13.11M |
| March 31, 2016 | 6.750M |
| December 31, 2015 | 10.65M |
| September 30, 2015 | 2.854M |
| June 30, 2015 | 5.377M |
| March 31, 2015 | 9.500M |
| December 31, 2014 | 8.965M |
| September 30, 2014 | 1.005M |
| June 30, 2014 | 2.001M |
| March 31, 2014 | 2.644M |
| December 31, 2013 | 0.0088M |
| September 30, 2013 | 0.076M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
18.09M
Minimum
Dec 2023
123.76M
Maximum
Mar 2021
56.76M
Average
48.65M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 2.764B |
| Madrigal Pharmaceuticals Inc | 1.082B |
| Galectin Therapeutics Inc | 25.89M |
| Viking Therapeutics Inc | 967.52M |
| 89bio Inc | 577.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.81M |
| Shareholders Equity (Quarterly) | 7.281M |